| Publications | PubMed=6244232 Richard D. Williams; Human urologic cancer cell lines. Invest. Urol. 17:359-363(1980) PubMed=3708594 John R.W. Masters, Peter J. Hepburn, Lawrence Walker, Wilma J. Highman, Ludwik K. Trejdosiewicz, Susan Povey, Mohamed Parkar, Bridget T. Hill, Peter N. Riddle, Leonard Maurice Franks; Tissue culture model of transitional cell carcinoma: characterization of twenty-two human urothelial cell lines. Cancer Res. 46:3630-3636(1986) PubMed=3800330 Maria Debiec-Rychter, Britta Christensen, Jorgen Kieler, Ching Y. Wang; Chromosomal characterization and isoenzyme pattern of non-malignant and malignant human urothelial cell lines. Anticancer Res. 6:1237-1244(1986) PubMed=7905254 Britta Christensen, Claus Hansen, Jorgen Kieler, Jacqueline Schmidt; Identity of non-malignant human urothelial cell lines classified as transformation grade I (TGrI) and II (TGrII). Anticancer Res. 13:2187-2191(1993) PubMed=8900435; DOI=10.1002/(SICI)1097-0215(19961009)68:2<239::AID-IJC17>3.0.CO;2-5 Arkadiusz Grzegorz Klopocki, Anna Krop-Watorek, Danuta Dus, Maciej Ugorski; Adhesion of human uroepithelial cells to E-selectin: possible involvement of sialosyl LewisA-ganglioside. Int. J. Cancer 68:239-244(1996) PubMed=11416159; DOI=10.1073/pnas.121616198; PMCID=PMC35459 John R.W. Masters, Jim A. Thomson, Bernadette Daly-Burns, Yvonne A. Reid, Wilhelm Gerhard Dirks, Phil Packer, Lorraine Hellenga Toji, Tadao Ohno, Hideyuki Tanabe, Colin Francis Arlett, Lloyd R. Kelland ...Show all 16 authors... , Maureen Harrison, Arvind K. Virmani, Timothy H. Ward, Karen L. Ayres, Paul G. Debenham; Show fewer authors Short tandem repeat profiling provides an international reference standard for human cell lines. Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001) PubMed=15846775; DOI=10.1002/gcc.20166 Sarah V. Williams, Jacqui Adams, Jane Coulter, Brenda M. Summersgill, Janet M. Shipley, Margaret Anne Knowles; Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro. Genes Chromosomes Cancer 43:315-328(2005) PubMed=23401075; DOI=10.1002/path.4176 Ya-Nan Guo, Yvonne Chekaluk, Jian-Ming Zhang, Jin-Yan Du, Nathanael S. Gray, Chin-Lee Wu, David Joseph Kwiatkowski; TSC1 involvement in bladder cancer: diverse effects and therapeutic implications. J. Pathol. 230:17-27(2013) PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057 Carolyn D. Hurst, Fiona M. Platt, Margaret Anne Knowles; Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur. Urol. 65:367-369(2014) PubMed=29732388; DOI=10.3233/BLC-180167; PMCID=PMC5929350 Tahlita C.M. Zuiverloon, Florus Christiaan de Jong, James C. Costello, Dan Theodorescu; Systematic review: characteristics and preclinical uses of bladder cancer cell lines. Bladder Cancer 4:169-183(2018) PubMed=30193179; DOI=10.1016/j.jmbbm.2018.08.036 Joanna Raczkowska, Szymon Prauzner-Bechcicki; Discrimination between HCV29 and T24 by controlled proliferation of cells co-cultured on substrates with different elasticity. J. Mech. Behav. Biomed. Mater. 88:217-222(2018) |